Illumina has released Illumina Dynamic Read Analysis for Genomics (DRAGEN) v4.0 as its most accurate and comprehensive secondary analysis platform. The new features allow laboratories to expand capabilities in analysis in oncology, pharmacogenomics, single-cell sequencing, and population genomics.
The expanded suite of capabilities includes the following:
- DRAGEN v4.0 enables the calling of 20 Tier 1 genes and supports the genotyping of complex pharmacogenetic (PGx) genes. It powers insights for optimal genotype and metabolism status.
- DRAGEN v4.0 integrates Expansion Hunter v5 with an expanded catalog of short tandem repeat (STR) loci.
- There is improved access to whole-genome sequencing, allowing researchers and labs to leverage the platform with low-pass sequencing data.
- DRAGEN v4.0 introduces single-cell assay for transposase-accessible chromatin with sequencing (ATAC-Seq) and single-cell multinomics. The single-cell ATAC-Seq pipeline allows single-cell resolution profiling of chromatin accessibility.
